Now Could Be the Perfect Time to Buy This Under-the-Radar COVID Vaccine Stock
You might be kicking yourself that you didn't buy shares of coronavirus vaccine leader Moderna (NASDAQ: MRNA) earlier this year. The biotech's vaccine is now on the market in the U.S. and its market cap has skyrocketed.
But there are still other COVID-19 vaccines potentially on the way that could ultimately achieve commercial success. Their stocks could also be big winners, perhaps even bigger than Moderna's. It's not too late at all to get in on up-and-coming biotechs with promising vaccines in development. Actually, now could be the perfect time to buy one under-the-radar COVID-19 vaccine stock -- Altimmune (NASDAQ: ALT).
Image source: Getty Images.
Source Fool.com
